+

Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

Close
HomeQuizzoneWhatsappShare Flash Reads
 

Weed stocks are sliding as Canada becomes the 2nd country to legalize marijuana

Oct 17, 2018, 17:06 IST

A budtender pours marijuana from a jar at Perennial Holistic Wellness Center medical marijuana dispensary, which opened in 2006, on July 25, 2012 in Los Angeles, California. The Los Angeles City Council has unanimously voted to ban storefront medical marijuana dispensaries and to order them to close or face legal action. The council also voted to instruct staff to draw up a separate ordinance for consideration in about three months that might allow dispensaries that existed before a 2007 moratorium on new dispensaries to continue to operate. It is estimated that Los Angeles has about one thousand such facilities. The ban does not prevent patients or cooperatives of two or three people to grow their own in small amounts. Californians voted to legalize medical cannabis use in 1996, clashing with federal drug laws. The state Supreme Court is expected to consider ruling on whether cities can regulate and ban dispensaries.David McNew/Getty

Advertisement
  • Canada on Wednesday became the second country to officially legalize marijuana.
  • Marijuana stocks were trading down by 2% to 7% ahead of the opening bell.
  • Watch Canopy Growth, Tilray, and Cronos trade in real time.

Weed stocks were set to slide at Wednesday's opening bell after Canada become the second country to officially legalize marijuana. Three of the largest marijuana producers by market cap - Canopy Growth, Tilray, and Cronos - were trading down by 2% to 7%.

Here's the scoreboard:

On Wednesday, Canada became the first G7 country - and second country in the world after Uruguay - to legalize marijuana for all adults. Each Canadian province has set its own age limit and rules on how to sell the drug - with some opting for storefronts and others pushing business online.

And while many Canadians may be celebrating their ability to freely use the drug, the coming legalization had been a boon for producers operating in the country as their market values exploded amid increasing interest from investors.

Advertisement

Canopy Growth, for example, has seen its market capitalization grow 128% to $12.2 billion after Constellation Brands - the beverage giant behind Corona beer and Svedka vodka - announced a $4 billion investment. Its rival Tilray has seen its market value explode by 555% over that time after making various supply deals.

On Tuesday, analysts at Benchmark said Canada's recreational cannabis market could reach 10.5 billion Canadian dollars by 2023 and suggested that Tilray would continue to lead the pack.

"We expect Tilray to acquire a meaningful share of the Canadian cannabis market based on initial supply agreements and through its first mover advantage in building production scale and strengthening national brands and products across a broad and expanding category," the analyst Mike Hickey said. He has a $200 price target for the stock - 26% above where shares settled Tuesday.

Markets Insider

NOW WATCH: Here's what caffeine does to your body and brain

Next Article